nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ADRB2—Arf6 trafficking events—VAMP3—Crohn's disease	0.0759	0.0897	CbGpPWpGaD
Ephedrine—Amphetamine—SLC22A5—Crohn's disease	0.0565	0.366	CrCbGaD
Ephedrine—Methamphetamine—SLC22A5—Crohn's disease	0.0524	0.339	CrCbGaD
Ephedrine—Pseudoephedrine—TNF—Crohn's disease	0.0457	0.295	CrCbGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IL23A—Crohn's disease	0.0286	0.0338	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0258	0.0305	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0258	0.0305	CbGpPWpGaD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.0223	0.0264	CbGpPWpGaD
Ephedrine—BCHE—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.0199	0.0236	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0174	0.0205	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0174	0.0205	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.0161	0.019	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.0156	0.0184	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.0139	0.0164	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—MTMR3—Crohn's disease	0.0132	0.0157	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—MTMR3—Crohn's disease	0.0118	0.014	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.0117	0.0139	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.0117	0.0139	CbGpPWpGaD
Ephedrine—ADRB2—Arf6 trafficking events—ITGA4—Crohn's disease	0.0117	0.0138	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.0112	0.0132	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.0108	0.0128	CbGpPWpGaD
Ephedrine—SLC18A2—Dopaminergic Neurogenesis—STAT3—Crohn's disease	0.0101	0.0119	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—MLN—Crohn's disease	0.00905	0.0107	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00892	0.0106	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00826	0.00977	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00809	0.00957	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00789	0.00933	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00789	0.00933	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—IL1B—Crohn's disease	0.00778	0.00921	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—IL1B—Crohn's disease	0.00769	0.0091	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00764	0.00904	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00738	0.00873	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.0073	0.00863	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00724	0.00857	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00632	0.00748	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—SBSPON—Crohn's disease	0.00625	0.00739	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00614	0.00727	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00599	0.00709	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00596	0.00705	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00596	0.00705	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00586	0.00693	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—GPR65—Crohn's disease	0.00583	0.0069	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.00582	0.00688	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—TNF—Crohn's disease	0.00565	0.00668	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—TNF—Crohn's disease	0.00558	0.0066	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—SBSPON—Crohn's disease	0.00558	0.0066	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00556	0.00657	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—MLN—Crohn's disease	0.00552	0.00653	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00545	0.00645	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IFNG—Crohn's disease	0.00535	0.00633	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00521	0.00617	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00502	0.00594	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00501	0.00593	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—CXCL8—Crohn's disease	0.00497	0.00588	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00491	0.00581	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00485	0.00573	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ACKR2—Crohn's disease	0.00481	0.00569	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00467	0.00552	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—MLN—Crohn's disease	0.00456	0.0054	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00452	0.00535	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00451	0.00533	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00447	0.00529	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00426	0.00504	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0042	0.00496	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00415	0.00491	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00401	0.00474	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00401	0.00474	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00388	0.00459	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00386	0.00457	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.00382	0.00452	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.0038	0.0045	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00371	0.00439	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.00355	0.0042	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00342	0.00404	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00333	0.00393	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00332	0.00393	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00321	0.0038	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCR9—Crohn's disease	0.00316	0.00374	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.00312	0.00369	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00311	0.00368	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00301	0.00356	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.00299	0.00353	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00296	0.00351	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—GPR65—Crohn's disease	0.00294	0.00348	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00293	0.00346	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.00283	0.00335	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00283	0.00334	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00282	0.00334	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IL6—Crohn's disease	0.00279	0.0033	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00278	0.00328	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00275	0.00325	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00269	0.00319	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00263	0.00311	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—MLN—Crohn's disease	0.00258	0.00305	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.00253	0.003	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.0025	0.00295	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ACKR2—Crohn's disease	0.00247	0.00292	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00242	0.00287	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MLN—Crohn's disease	0.00234	0.00277	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PLA2G4F—Crohn's disease	0.00223	0.00264	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.00223	0.00264	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.00216	0.00256	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCR6—Crohn's disease	0.0021	0.00248	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.00201	0.00238	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.002	0.00237	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PLA2G4F—Crohn's disease	0.00199	0.00236	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.00196	0.00232	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTMR3—Crohn's disease	0.0019	0.00225	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTGER4—Crohn's disease	0.00184	0.00218	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.00182	0.00216	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR9—Crohn's disease	0.00179	0.00211	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00177	0.00209	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.00176	0.00209	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTMR3—Crohn's disease	0.00169	0.002	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.00167	0.00198	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	0.00166	0.00197	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	0.00162	0.00192	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.00153	0.00181	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	0.00151	0.00178	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—FADS1—Crohn's disease	0.00148	0.00175	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	0.00146	0.00173	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00143	0.00169	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX4—Crohn's disease	0.00139	0.00164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MLN—Crohn's disease	0.00138	0.00164	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00138	0.00163	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.00135	0.0016	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GCKR—Crohn's disease	0.00134	0.00158	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.00134	0.00158	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.00134	0.00158	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FADS1—Crohn's disease	0.00132	0.00156	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00131	0.00155	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.0013	0.00154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.00127	0.0015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	0.00127	0.0015	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00126	0.00149	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX4—Crohn's disease	0.00124	0.00146	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GCKR—Crohn's disease	0.00119	0.00141	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00118	0.0014	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.00116	0.00137	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.00114	0.00135	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	0.00111	0.00131	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.00108	0.00127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	0.00108	0.00127	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.00107	0.00127	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00107	0.00127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	0.00105	0.00124	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00104	0.00123	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00104	0.00123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.000975	0.00115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.000959	0.00113	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000956	0.00113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000947	0.00112	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000943	0.00112	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000899	0.00106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.000891	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.000888	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000887	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000859	0.00102	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000853	0.00101	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000836	0.000989	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.000816	0.000966	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.000806	0.000954	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.00078	0.000922	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.000768	0.000908	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000752	0.000889	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000746	0.000883	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—Crohn's disease	0.000701	0.000829	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.000694	0.000821	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.000683	0.000808	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000676	0.0008	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000675	0.000799	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000673	0.000796	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.000635	0.000751	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	0.000625	0.00074	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000622	0.000736	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000609	0.00072	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	0.00059	0.000698	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL3—Crohn's disease	0.000576	0.000681	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000574	0.000679	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000565	0.000668	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000559	0.000661	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000557	0.000659	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	0.000505	0.000598	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	0.000505	0.000597	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000504	0.000596	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000488	0.000578	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	0.000481	0.000569	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000476	0.000563	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000461	0.000546	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000461	0.000545	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	0.000459	0.000543	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	0.000436	0.000515	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—Crohn's disease	0.000426	0.000504	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	0.000419	0.000495	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000418	0.000494	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000417	0.000494	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	0.000403	0.000477	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000398	0.000471	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000382	0.000451	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—Crohn's disease	0.00038	0.000449	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.00038	0.000449	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—Crohn's disease	0.000373	0.000441	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.00036	0.000426	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000346	0.00041	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	0.000334	0.000395	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—Crohn's disease	0.000332	0.000393	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TYK2—Crohn's disease	0.000284	0.000336	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAK2—Crohn's disease	0.000271	0.000321	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	0.000247	0.000293	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—Crohn's disease	0.000235	0.000278	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	0.000235	0.000278	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	0.000224	0.000265	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	0.000205	0.000242	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—Crohn's disease	0.000199	0.000235	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	0.000195	0.00023	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	0.000165	0.000195	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—Crohn's disease	0.000139	0.000164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	0.000115	0.000136	CbGpPWpGaD
